---
figid: PMC8784548__fphar-12-830340-g001
figtitle: Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis
  by Targeting Wnt/Beta-Catenin Signaling
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8784548
filename: fphar-12-830340-g001.jpg
figlink: /pmc/articles/PMC8784548/figure/F1/
number: F1
caption: Modulators for inhibiting tubular EMT and their potential targeted components
  of Wnt/β-catenin pathway. LRP, lipoprotein receptor-related protein; Dvl, disheveled;
  GSK3β, glycogen synthase kinase-3β; APC, adenomatous polyposis coli; MAF, 25-O-methylalisol
  F; AS-IV, Astragaloside IV; ATL-1, Atractylenolide I; SIK1, salt inducible kinase
  1; RAGE, receptor of advanced glycation end-products; ERK, extracellular signal-regulated
  kinase; MMP, matrix metalloproteinase; WISP1, Wnt-inducible signaling pathway protein-1;
  CRP, C-reactive protein; FKN, fractalkine; RSPO1, R-spondin 1; LGR4, leucine-rich
  repeat-containing G protein coupled receptor 4; CFTR, cystic fibrosis transmembrane
  conductance regulator; DOCK4, dedicator of cytokinesis 4; AMPK, AMP-activated protein
  kinase; FHL2, four and a half LIM domain protein 2.
papertitle: Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney
  Fibrosis by Targeting Wnt/β-Catenin Signaling.
reftext: Lichao Hu, et al. Front Pharmacol. 2021;12:830340.
year: '2021'
doi: 10.3389/fphar.2021.830340
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: epithelial-mesenchymal transition | tubular epithelial cell | Wnt/β-catenin
  signaling | kidney fibrosis | myofibroblast
automl_pathway: 0.9431149
figid_alias: PMC8784548__F1
figtype: Figure
redirect_from: /figures/PMC8784548__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8784548__fphar-12-830340-g001.html
  '@type': Dataset
  description: Modulators for inhibiting tubular EMT and their potential targeted
    components of Wnt/β-catenin pathway. LRP, lipoprotein receptor-related protein;
    Dvl, disheveled; GSK3β, glycogen synthase kinase-3β; APC, adenomatous polyposis
    coli; MAF, 25-O-methylalisol F; AS-IV, Astragaloside IV; ATL-1, Atractylenolide
    I; SIK1, salt inducible kinase 1; RAGE, receptor of advanced glycation end-products;
    ERK, extracellular signal-regulated kinase; MMP, matrix metalloproteinase; WISP1,
    Wnt-inducible signaling pathway protein-1; CRP, C-reactive protein; FKN, fractalkine;
    RSPO1, R-spondin 1; LGR4, leucine-rich repeat-containing G protein coupled receptor
    4; CFTR, cystic fibrosis transmembrane conductance regulator; DOCK4, dedicator
    of cytokinesis 4; AMPK, AMP-activated protein kinase; FHL2, four and a half LIM
    domain protein 2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP6
  - LGR4
  - RSPO1
  - APC
  - PROC
  - CTNNB1
  - FHL2
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LRP5
  - AXIN1
  - AXIN2
  - GPT
  - DLEU2
  - MAF
  - MAFA
  - MAFB
  - MAFF
  - MAFG
  - MAFK
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - SIK1
  - MAPK3
  - MMP2
  - AGER
  - MOK
  - CCN4
  - CRP
  - CSRP1
  - PPIAP10
  - SERPINA4
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - GSK3B
  - CFTR
  - DOCK4
  - ITK
  - SLC22A3
  - MMP7
  - S100A4
  - ATL1
  - AIFM2
  - SNAI1
  - TWIST1
  - HNF4A
---
